NON-SYNDROMIC RETINITIS PIGMENTOSA

Clinical trials for NON-SYNDROMIC RETINITIS PIGMENTOSA explained in plain language.

Never miss a new study

Get alerted when new NON-SYNDROMIC RETINITIS PIGMENTOSA trials appear

Sign up with your email to follow new studies for NON-SYNDROMIC RETINITIS PIGMENTOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Gene therapy and High-Tech glasses aim to restore sight in blinding eye disease

Disease control Ongoing

This early-stage study is testing the safety of a new gene therapy called GS030 for people with retinitis pigmentosa, a genetic eye disease that causes vision loss. Participants receive a single injection into the eye and then use special stimulating glasses. The main goal is to …

Matched conditions: NON-SYNDROMIC RETINITIS PIGMENTOSA

Phase: PHASE1, PHASE2 • Sponsor: GenSight Biologics • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

NON-SYNDROMIC RETINITIS PIGMENTOSA

Get alerted when new NON-SYNDROMIC RETINITIS PIGMENTOSA trials appear

Gene therapy and High-Tech glasses aim to restore sight in blinding eye disease